glp-1/gip medication Tirzepatide Rx GLP-1 + GIP Injections -

Description

Plaintiffs in these lawsuits allege that some patients developed life-altering complications including gastroparesis, bowel obstruction, cyclic vomiting syndrome, gallbladder disease, pulmonary aspiration during surgery, and sudden vision loss associated with non-arteritic anterior ischemic optic neuropathy (NAION)

In light of the restriction on the importation of biotechnological APIs and given the lack of effective enforcement by ANVISA, which suffers from staffing shortages, it is foreseeable - and has already been observed - that clinics are directing their activities almost exclusively to tirzepatide and the situation is likely to worsen

However, further research is needed to understand their full potential and all details of their mechanism of action, which will enable to expand the therapeutic indications and to determine their optimal use in clinical practice